Chronic Plaque Psoriasis Completed Phase 4 Trials for Streptococcus pneumoniae type 19a capsular polysaccharide antigen (DB10337)

IndicationStatusPhase
DBCOND0033442 (Chronic Plaque Psoriasis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00493324Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque PsoriasisPrevention